Home Seattle Genetics' Antibody Drug Conjugate Tech Prominent at ASCO Meeting
 

Keywords :   


Seattle Genetics' Antibody Drug Conjugate Tech Prominent at ASCO Meeting

2014-06-01 13:32:00| Biotech - Topix.net

Seattle Genetics, the company that pioneered the antibody-drug conjugate platform in Adcetris, the Hodgkin's lymphoma treatment, has data presented from a handful of collaborator programs at the American Society of Clinical Oncology's 50th Annual Meeting being held May 30 to June 3, 2014 in Chicago, IL.

Tags: tech meeting drug seattle

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »